> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Imarc Details BIMO Findings
- URL: https://www.fdaweb.com/imarc-details-bimo-findings/
- Published: 2019-06-19T12:00:00.000Z
- Updated: 2026-09-15T01:33:50.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144369

Imarc, a medical device contract research organization, says that FDA Bioresearch Monitoring metrics for FY 2017 show that 36% of the inspected sponsors, monitors, or contract research organizations had some type of deficiency resulting in either a Voluntary Action Indicated outcome or an Official Action Indicated outcome. In a [report](https://cdn2.hubspot.net/hubfs/149400/Study%20Clean-up%202019/ClinicalStudyCleanup.pdf?%5F%5Fhssc=29837664.1.1560954025032&%5F%5Fhstc=29837664.6803084b066329258536a22ba499986c.1560954025031.1560954025031.1560954025031.1&%5F%5Fhsfp=3743606026&hsCtaTracking=638d5f5d-d46e-4411-a6a2-0a0b0365ed07%7C389b16c2-2836-44f5-bc6f-6e7203413e4c&ref=fdaweb.com), Imarc says the seven most common causes of a non-compliant study were: poorly written protocol, mismanaged study team, inadequate training, inadequate documentation, lack of resources, ineffective leadership, and high turnover. The report also gives five suggestions to get studies back on track.